Literature DB >> 2141830

Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients.

D Dompmartin1, A Dompmartin, A M Deluol, E Grosshans, J P Coulaud.   

Abstract

The results of a study on onychomycosis in AIDS related complex and AIDS patients presenting for dermatology consultation at an infectious diseases department are reported. The clinical results showed that most patients presented a proximal white superficial onychomycosis. The association with a clinical interdigital involvement was rare, but the association with a mycotic plantar keratoderma was more frequent. The laboratory results showed that dermatophytes were the most frequent etiologic agents, especially Trichophyton rubrum (58%). Although most of these patients presented an oral candidiasis, Candida albicans was isolated only in seven patients' nails. Surprisingly, Pityrosporum ovale was the only etiologic organism that was found in two patients. This result was confirmed with a histologic examination.

Entities:  

Mesh:

Year:  1990        PMID: 2141830     DOI: 10.1111/j.1365-4362.1990.tb04755.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  12 in total

Review 1.  Onychomycosis in the elderly.

Authors:  A K Gupta
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  Orocutaneous Manifestations as Markers of Disease Progression in HIV Infection in Indian Setting.

Authors:  Y K Sharma; Mps Sawhney; D S Bhakuni; V Gera
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Study of onychomycosis in Córdoba, Spain: prevailing fungi and pattern of infection.

Authors:  A Vélez; M J Linares; J C Fenández-Roldán; M Casal
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

Review 4.  Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.

Authors:  R Davis; J A Balfour
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

Review 5.  Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.

Authors:  V N Joish; E P Armstrong
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 6.  Management of onychomycoses.

Authors:  M Niewerth; H C Korting
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

7.  Extensive dermatophytoses caused by Trichophyton mentagrophytes and Microsporum canis in a patient with AIDS.

Authors:  M Lowinger-Seoane; J M Torres-Rodríguez; N Madrenys-Brunet; S Aregall-Fusté; P Saballs
Journal:  Mycopathologia       Date:  1992-12       Impact factor: 2.574

8.  Quality of life of persons with onychomycosis.

Authors:  D P Lubeck; D L Patrick; P McNulty; S K Fifer; J Birnbaum
Journal:  Qual Life Res       Date:  1993-10       Impact factor: 4.147

9.  Cutaneous manifestations of HIV-a detailed study of morphological variants, markers of advanced disease, and the changing spectrum.

Authors:  Biju Vasudevan; Amitabh Sagar; Ashish Bahal; Ap Mohanty
Journal:  Med J Armed Forces India       Date:  2012-01-18

Review 10.  Onychomycosis: pathogenesis, diagnosis, and management.

Authors:  B E Elewski
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.